BAM Logo

Immunoreactive trypsinogen newborn screening

[CNN-3 Tripsina inmunorreactiva, cribado neonatal]

EPTIS factsheet 956109 | Last revision 2022-08-31 | URL: https://www.eptis.bam.de/pts956109 https://www.eptis.bam.de/pts956109

PT provider
PT provider Centro de Hemoterapia y Hemodonación de Castilla y León Centro de Hemoterapia y Hemodonación de Castilla y León
Based in Spain
Language(s) English, Spanish
Product groups Human test material
Testing fields Analytical chemistry
Medical analysis
Technical details
Test item Tested property Testing method
Dry blood spots tripsinogen -
Aims of the PT scheme
Target group of participants Newborn screening labs
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 10
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee
Regularly operated Yes (2 monthly)
Year of first operation 2019
Contact details of the PT provider
Provider Contact person
Centro de Hemoterapia y Hemodonación de Castilla y León
Paseo de Filipinos s/n

Phone: +34983418823
Web: https://www.controlcribado.centrodehemoterapiacyl.es https://www.controlcribado.centrodehemoterapiacyl.es
Arancha Barrera
Phone: +34983418823
Email: geclid.chem@saludcastillayleon.es geclid.chem@saludcastillayleon.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.22